+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Occlusive Coronary Artery Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768116
  • Report
  • 46 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • Eli Lilly and Co
  • MORE
The global clinical trial report- “2019 Occlusive Coronary Artery Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Occlusive Coronary Artery Disease. It presents in-depth analysis of Occlusive Coronary Artery Disease clinical trials across markets and companies. The research work is for providing complete understanding into trends in Occlusive Coronary Artery Disease.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Occlusive Coronary Artery Disease clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Occlusive Coronary Artery Disease

The research work is prepared through extensive and continuous research on Occlusive Coronary Artery Disease trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Occlusive Coronary Artery Disease patients are identified
  • The report includes panorama of Occlusive Coronary Artery Disease clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Occlusive Coronary Artery Disease clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • Eli Lilly and Co
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Occlusive Coronary Artery Disease Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Occlusive Coronary Artery Disease Clinical Trials by Region
2.2.2 Average Enrollment of Occlusive Coronary Artery Disease Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Occlusive Coronary Artery Disease Treatment, 2019

3. Region wise Occlusive Coronary Artery Disease Clinical Trials
3.1 Asia Pacific Occlusive Coronary Artery Disease Clinical Trials by Country
3.2 Europe Occlusive Coronary Artery Disease Clinical Trials by Country
3.3 North America Occlusive Coronary Artery Disease Clinical Trials by Country
3.4 Middle East and Africa Occlusive Coronary Artery Disease Clinical Trials by Country
3.5 South and Central America Occlusive Coronary Artery Disease Clinical Trials by Country

4. Occlusive Coronary Artery Disease Clinical Trial Trends
4.1 Start Year wise Occlusive Coronary Artery Disease Clinical Trials
4.2 Phase wise Occlusive Coronary Artery Disease Clinical Trials
4.3 Trial Status wise Occlusive Coronary Artery Disease Clinical Trials
4.4 Trial Type wise Occlusive Coronary Artery Disease Clinical Trials

5. Occlusive Coronary Artery Disease Average Enrollment Trends
5.1 Average Enrollment in Occlusive Coronary Artery Disease Trials by Year
5.2 Average Enrollment in Occlusive Coronary Artery Disease Trials by Phase
5.3 Average Enrollment in Occlusive Coronary Artery Disease Trials by Status
5.4 Average Enrollment in Occlusive Coronary Artery Disease Trials by Type of Trial

6. Companies Participating in Occlusive Coronary Artery Disease Clinical Trials
6.1 Occlusive Coronary Artery Disease Trials by Sponsor Type
6.2 Occlusive Coronary Artery Disease Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Occlusive Coronary Artery Disease Trials- Phase 1
7.2 Occlusive Coronary Artery Disease Trials- Phase 2
7.3 Occlusive Coronary Artery Disease Trials- Phase 3
7.4 Occlusive Coronary Artery Disease Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Occlusive Coronary Artery Disease Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Figure 5: Europe - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Figure 7: North America - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Figure 9: Occlusive Coronary Artery Disease Clinical Trials by Phase
Figure 10: Occlusive Coronary Artery Disease Clinical Trials by Trial Status
Figure 11: Occlusive Coronary Artery Disease Clinical Trials by Type
Figure 12: Occlusive Coronary Artery Disease Clinical Trials by Sponsor Type
Figure 13: Occlusive Coronary Artery Disease Clinical Trials by Leading Sponsors
Figure 14: Occlusive Coronary Artery Disease Average Enrollment by Phase
Figure 15: Occlusive Coronary Artery Disease Average Enrollment by Trial Status
Figure 16: Occlusive Coronary Artery Disease Average Enrollment by Type
Figure 17: Occlusive Coronary Artery Disease- Average Enrolment by Type of Sponsors
Figure 18: Occlusive Coronary Artery Disease- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Occlusive Coronary Artery Disease Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Table 5: Europe - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Table 7: North America - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Occlusive Coronary Artery Disease Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Occlusive Coronary Artery Disease Average Enrollment by Phase
Table 15: Occlusive Coronary Artery Disease Average Enrollment by Trial Status
Table 16: Occlusive Coronary Artery Disease Average Enrollment by Type
Table 17: Occlusive Coronary Artery Disease- Average Enrolment by Type of Sponsors
Table 18: Occlusive Coronary Artery Disease- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • AstraZeneca Plc
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • Eli Lilly and Co
  • Johnson & Johnson
  • Matrizyme Pharma Corp
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768116
Adroll
adroll